Sodium–glucose transporter as a novel therapeutic target in disease

European Journal of Pharmacology

Volumn 822, Issue , 2018, Pages 25-31

  Yamazaki, Yui ^a   Harada, Shinichi ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cancer; Cardiac disease; Cerebral ischemia; Intestinal ischemia; SGLT

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 3; SODIUM ION; TUMOR MARKER; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; CANCER CELL LINE; CANCER THERAPY; CARDIOMYOPATHY; CELL SURVIVAL; DISEASE EXACERBATION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; INTESTINE ISCHEMIA; NERVE CELL LESION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SODIUM TRANSPORT; UPREGULATION; ANIMAL; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM; PATHOLOGY; PROCEDURES;

ANIMALS; BRAIN ISCHEMIA; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SODIUM-GLUCOSE TRANSPORT PROTEINS;

EID: 85040698843     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2018.01.003     Document Type: Review

References (99)

1. Banerjee, S.K., McGaffin, K.R., Pastor-Soler, N.M., Ahmad, F., SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc. Res. 84 (2009), 111–118.
2. Bradley, R.F., Schonfeld, A., Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics 17 (1962), 322–326.
3. Brown, R.S., Wahl, R.L., Overexpression of glut‐1 glucose transporter in human breast cancer an immunohistochemical study. Cancer 72 (1993), 2979–2985.
4. Burdakov, D., Luckman, S.M., Verkhratsky, A., Glucose-sensing neurons of the hypothalamus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 (2005), 2227–2235.
5. Capes, S.E., Hunt, D., Malmberg, K., Pathak, P., Gerstein, H.C., Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001), 2426–2432.
6. Chandran, D., Co-option of developmentally regulated plant SWEET transporters for pathogen nutrition and abiotic stress tolerance. IUBMB Life 67 (2015), 461–471.
7. Chen, J.-H., Kuo, H.-C., Lee, K.-F., Tsai, T.-H., Global proteomic analysis of brain tissues in transient ischemia brain damage in rats. Int. J. Mol. Sci. 16 (2015), 11873–11891.
8. Chen, L.-Q., Hou, B.-H., Lalonde, S., Takanaga, H., Hartung, M.L., Qu, X.-Q., Guo, W.-J., Kim, J.-G., Underwood, W., Chaudhuri, B., Chermak, D., Antony, G., White, F.F., Somerville, S.C., Mudgett, M.B., Frommer, W.B., Sugar transporters for intercellular exchange and nutrition of pathogens. Nature 468 (2010), 527–532.
9. Cheng, X., Ni, B., Zhang, F., Hu, Y., Zhao, J., High glucose-induced oxidative stress mediates apoptosis and extracellular matrix metabolic imbalances possibly via p38 MAPK activation in rat nucleus pulposus cells. J. Diabetes Res., 2016, 2016, 3765173.
10. Cuomo, O., Vinciguerra, A., Cerullo, P., Anzilotti, S., Brancaccio, P., Bilo, L., Scorziello, A., Molinaro, P., Di Renzo, G., Pignataro, G., Ionic homeostasis in brain conditioning. Front. Neurosci., 9, 2015, 277.
11. Danaei, G., Lawes, C.M., Vander Hoorn, S., Murray, C.J., Ezzati, M., Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368 (2006), 1651–1659.
12. de Leeuw, A.E., de Boer, R.A., Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects. Eur. Hear J. Cardiovasc. Pharmacother. 2 (2016), 244–255.
13. Doi, Y., Ninomiya, T., Hata, J., Fukuhara, M., Yonemoto, K., Iwase, M., Iida, M., Kiyohara, Y., Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 41 (2010), 203–209.
14. Dreier, J.P., The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat. Med. 17 (2011), 439–447.
15. Drenckhahn, C., Koch, S.P., Dümmler, J., Kohl-Bareis, M., Steinbrink, J., Dreier, J.P., A validation study of the use of near-infrared spectroscopy imaging in primary and secondary motor areas of the human brain. Epilepsy Behav. 49 (2015), 118–125.
16. Espinoza-Rojo, M., Iturralde-Rodríguez, K.I., Chánez-Cárdenas, M.-E., Ruiz-Tachiquín, M.E., Aguilera, P., Glucose transporters regulation on ischemic brain: possible role as therapeutic target. Cent. Nerv. Syst. Agents Med. Chem. 10 (2010), 317–325.
17. Freeman, S.L., Bohan, D., Darcel, N., Raybould, H.E., Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am. J. Physiol. - Gastrointest. Liver Physiol., 291, 2006.
18. Fuchs-Tarlovsky, V., Rivera, M.A.C., Altamirano, K.A., Lopez-Alvarenga, J.C., Ceballos-Reyes, G.M., Antioxidant supplementation has a positive effect on oxidative stress and hematological toxicity during oncology treatment in cervical cancer patients. Support. Care Cancer 21 (2013), 1359–1363.
19. Fumagalli, A., Drost, J., Suijkerbuijk, S.J.E., van Boxtel, R., de Ligt, J., Offerhaus, G.J., Begthel, H., Beerling, E., Tan, E.H., Sansom, O.J., Cuppen, E., Clevers, H., van Rheenen, J., Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc. Natl. Acad. Sci. USA, 2017, 201701219.
20. Fung, C., Evans, E., Shin, D., Shin, B.-C., Zhao, Y., Sankar, R., Chaudhuri, G., Devaskar, S.U., Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice. J. Neurosci. Res. 88 (2010), 3386–3398.
21. Gentile, N.T., Seftchick, M.W., Huynh, T., Kruus, L.K., Gaughan, J., Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad. Emerg. Med. 13 (2006), 174–180.
22. Grell, A.-S., Thigarajah, R., Edvinsson, L., Samraj, A.K., Regulatory mechanism of endothelin receptor B in the cerebral arteries after focal cerebral ischemia. PLoS One, 9, 2014, e113624.
23. Grempler, R., Augustin, R., Froehner, S., Hildebrandt, T., Simon, E., Mark, M., Eickelmann, P., Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett. 586 (2012), 248–253.
24. Gribble, F.M., Williams, L., Simpson, A.K., Reimann, F., A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 (2003), 1147–1154.
25. Guijarro, M.V., Leal, J.F.M., Blanco-Aparicio, C., Alonso, S., Fominaya, J., Lleonart, M., Castellvi, J., Ramon y Cajal, S., Carnero, A., MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis 28 (2007), 2096–2104.
26. Hahn, S.S., Tang, Q., Zheng, F., Zhao, S., Wu, J., Chen, J., Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1. Cell Signal. 26 (2014), 639–647.
27. Harada, S., Fujita-Hamabe, W., Tokuyama, S., The importance of regulation of blood glucose levels through activation of peripheral 5’-AMP-activated protein kinase on ischemic neuronal damage. Brain Res. 1351 (2010), 254–263.
28. Harada, S., Fujita-Hamabe, W., Tokuyama, S., Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J. Pharmacol. Sci. 115 (2011), 155–163.
29. Harada, S., Fujita, W.H., Shichi, K., Tokuyama, S., The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res. 1279 (2009), 174–181.
30. Hotta, H., Uchida, S., Kagitani, F., Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex. Jpn. J. Physiol. 52 (2002), 383–393.
31. Huang, C.-Y., Hsiao, J.-K., Lu, Y.-Z., Lee, T.-C., Yu, L.C.-H., Anti-apoptotic PI3K/Akt signaling by sodium/glucose transporter 1 reduces epithelial barrier damage and bacterial translocation in intestinal ischemia. Lab. Investig. 91 (2011), 294–309.
32. Huber, S.M., Misovic, M., Mayer, C., Rodemann, H.-P., Dittmann, K., EGFR-mediated stimulation of sodium/glucose cotransport promotes survival of irradiated human A549 lung adenocarcinoma cells. Radiother. Oncol. 103 (2012), 373–379.
33. Ishikawa, N., Oguri, T., Isobe, T., Fujitaka, K., Kohno, N., SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn. J. Cancer Res. 92 (2001), 874–879.
34. Jiang, M., Li, J., Peng, Q., Liu, Y., Liu, W., Luo, C., Peng, J., Li, J., Yung, K.K.L., Mo, Z., Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J. Neuroinflamm., 11, 2014, 167.
35. Jojima, T., Tomotsune, T., Iijima, T., Akimoto, K., Suzuki, K., Aso, Y., Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes. Diabetol. Metab. Syndr., 8, 2016, 45.
36. Kashiwagi, Y., Nagoshi, T., Yoshino, T., Tanaka, T.D., Ito, K., Harada, T., Takahashi, H., Ikegami, M., Anzawa, R., Yoshimura, M., Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemia-reperfusion injury in mice. PLoS One, 10, 2015, e0130605.
37. Kiss, K., Baghy, K., Spisák, S., Szanyi, S., Tulassay, Z., Zalatnai, A., Löhr, J.-M., Jesenofsky, R., Kovalszky, I., Firneisz, G., Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. PLoS One, 10, 2015, e0128059.
38. Koizumi, H., Fujisawa, H., Suehiro, E., Shirao, S., Suzuki, M., Neuroprotective effects of ebselen following forebrain ischemia: involvement of glutamate and nitric oxide. Neurol. Med. Chir. (Tokyo) 51 (2011), 337–343.
39. Kurosaki, E., Ogasawara, H., Ipragliflozin and other sodium?Glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data. Pharmacol. Ther. 139 (2013), 51–59.
40. Lee, Y.J., Han, H.J., Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β Snail1, and β-catenin in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol. 298 (2010), 1263–1275.
41. Lee, Y.J., Suh, H.N., Han, H.J., Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol. 296 (2009), 1405–1416.
42. Li, J., McCullough, L.D., Effects of AMP-activated protein kinase in cerebral ischemia. J. Cereb. Blood Flow Metab. 30 (2010), 480–492.
43. Li, S.-Y., Jia, Y.-H., Sun, W.-G., Tang, Y., An, G.-S., Ni, J.-H., Jia, H.-T., Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic. Biol. Med. 48 (2010), 597–608.
44. Lin, X., Ma, L., Fitzgerald, R.L., Ostlund, R.E., Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Arch. Biochem. Biophys. 481 (2009), 197–201.
45. Marques, J.L., George, E., Peacey, S.R., Harris, N.D., Macdonald, I.A., Cochrane, T., Heller, S.R., Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet. Med. 14 (1997), 648–654.
46. +-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000), 591–603.
47. +-dependent and phlorizin-inhibitable transport of glucose and cycasin in brain endothelial cells. J. Neurochem. 70 (1998), 772–777.
48. Moloney, J.N., Cotter, T.G., ROS signalling in the biology of cancer. Semin. Cell Dev. Biol., 2017, 10.1016/j.semcdb.2017.05.023.
49. Mueckler, M., Caruso, C., Baldwin, S.A., Panico, M., Blench, I., Morris, H.R., Allard, W.J., Lienhard, G.E., Lodish, H.F., Sequence and structure of a human glucose transporter. Science 229 (1985), 941–945.
50. Mueckler, M., Thorens, B., The SLC2 (GLUT) family of membrane transporters. Mol. Asp. Med. 34 (2013), 121–138.
51. Murphy, T.H., Li, P., Betts, K., Liu, R., Two-photon imaging of stroke onset in vivo reveals that NMDA-receptor independent ischemic depolarization is the major cause of rapid reversible damage to dendrites and spines. J. Neurosci. 28 (2008), 1756–1772.
52. Nagamachi, S., Nishii, R., Wakamatsu, H., Mizutani, Y., Kiyohara, S., Fujita, S., Futami, S., Sakae, T., Furukoji, E., Tamura, S., Arita, H., Chijiiwa, K., Kawai, K., The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT. Ann. Nucl. Med. 27 (2013), 554–563.
53. Nagamatsu, S., Sawa, H., Wakizaka, A., Hoshino, T., Expression of facilitative glucose transporter isoforms in human brain tumors. J. Neurochem. 61 (1993), 2048–2053.
54. Nicholls, D.G., Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta 1787 (2009), 1416–1424.
55. O'Malley, D., Reimann, F., Simpson, A.K., Gribble, F.M., Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55 (2006), 3381–3386.
56. Ogbera, A.O., Oshinaike, O.O., Dada, O., Brodie-Mends, A., Ekpebegh, C., Glucose and lipid assessment in patients with acute stroke. Int. Arch. Med., 7, 2014, 45.
57. +-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes, 48, 1999.
58. Olsson, T., Viitanen, M., Asplund, K., Eriksson, S., Hägg, E., Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia 33 (1990), 244–249.
59. 2 /Akt/NF-κB pathway. J. Pineal Res., 2017, e12427.
60. Palazón, A., Aragonés, J., Morales-Kastresana, A., de Landázuri, M.O., Melero, I., Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin. Cancer Res. 18 (2012), 1207–1213.
61. Perez, M., Peinado-Serrano, J., Garcia-Heredia, J.M., Felipe-Abrio, I., Tous, C., Ferrer, I., Martin-Broto, J., Saez, C., Carnero, A., Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1). Oncotarget 7 (2016), 67033–67046.
62. Perez, M., Praena-Fernandez, J.M., Felipe-Abrio, B., Lopez-Garcia, M.A., Lucena-Cacace, A., Garcia, A., Lleonart, M., Roncador, G., Marin, J.J., Carnero, A., MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival. PLoS One, 8, 2013, e56169.
63. Pérez López, G., González Albarrán, O., Cano Megías, M., [Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus]. Nefrologia 30 (2010), 618–625.
64. Pistrosch, F., Ganz, X., Bornstein, S.R., Birkenfeld, A.L., Henkel, E., Hanefeld, M., Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol. 52 (2015), 889–895.
65. Poppe, R., Karbach, U., Gambaryan, S., Wiesinger, H., Lutzenburg, M., Kraemer, M., Witte, O.W., Koepsell, H., Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J. Neurochem. 69 (1997), 84–94.
66. Ramratnam, M., Sharma, R.K., D'Auria, S., Lee, S.J., Wang, D., Huang, X.Y.N., Ahmad, F., Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J. Am. Heart Assoc., 3, 2014, e000899.
67. Reske, S.N., Grillenberger, K.G., Glatting, G., Port, M., Hildebrandt, M., Gansauge, F., Beger, H.G., Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J. Nucl. Med. 38 (1997), 1344–1348.
68. Rizk, N.N., Rafols, J.A., Dunbar, J.C., Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res. 1096 (2006), 204–212.
69. Scafoglio, C., Hirayama, B.A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N.A., Huang, J., Koepsell, H., Barrio, J.R., Wright, E.M., Functional expression of sodium-glucose transporters in cancer. Proc. Natl. Acad. Sci. 112 (2015), 4111–4119.
70. Scheepers, A., Joost, H.-G., Schürmann, A., The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J. Parenter. Enter. Nutr. 28 (2004), 364–371.
71. Scheepers, A., Joost, H., Schurmann, A., The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J. Parenter. Enter. Nutr. 28 (2004), 364–371.
72. +-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Mol. Membr. Biol. 27 (2010), 137–144.
73. Stanley, W.C., Lopaschuk, G.D., Hall, J.L., McCormack, J.G., Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential Pharmacol. Interv. Cardiovasc. Res. 33 (1997), 243–257.
74. Su, L., Du, H., Dong, X., Zhang, X., Lou, Z., Raf kinase inhibitor protein regulates oxygen-glucose deprivation-induced PC12 cells apoptosis through the NF-κB and ERK pathways. J. Clin. Biochem. Nutr. 59 (2016), 86–92.
75. 18F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?. Gen. Thorac. Cardiovasc. Surg., 2017, 10.1007/s11748-017-0786-9.
76. Tahara, A., Takasu, T., Yokono, M., Imamura, M., Kurosaki, E., Characterization and comparison of sodium-glucose cotransporter 2 inhibitors: part 2. Antidiabetic effects in type 2 diabetic mice. J. Pharmacol. Sci. 131 (2016), 198–208.
77. Tazawa, S., Yamato, T., Fujikura, H., Hiratochi, M., Itoh, F., Tomae, M., Takemura, Y., Maruyama, H., Sugiyama, T., Wakamatsu, A., Isogai, T., Isaji, M., SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 76 (2005), 1039–1050.
78. Tong, Y., Li, S., Huang, C., EGFR induces DNA decomposition via phosphodiester bond cleavage. Sci. Rep., 7, 2017, 43698.
79. Turk, E., Zabel, B., Mundlos, S., Dyer, J., Wright, E.M., Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature 350 (1991), 354–356.
80. Vemula, S., Roder, K.E., Yang, T., Bhat, G.J., Thekkumkara, T.J., Abbruscato, T.J., A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J. Pharmacol. Exp. Ther. 328 (2009), 487–495.
81. Verma, R., Harris, N.M., Friedler, B.D., Crapser, J., Patel, A.R., Venna, V., McCullough, L.D., Reversal of the detrimental effects of post-stroke social isolation by pair-housing is mediated by activation of BDNF-MAPK/ERK in aged mice. Sci. Rep., 6, 2016, 25176.
82. Wang, Y., Denisova, J.V., Kang, K.S., Fontes, J.D., Zhu, B.T., Belousov, A.B., Neuronal gap junctions are required for NMDA receptor-mediated excitotoxicity: implications in ischemic stroke. J. Neurophysiol. 104 (2010), 3551–3556.
83. Wright, E.M., Hirayama, B.A., Loo, D.F., Active sugar transport in health and disease. J. Int. Med. 261 (2007), 32–43.
84. Wright, E.M., Loo, D.D.F., Hirayama, B.A., Biology of human sodium glucose transporters. Physiol. Rev. 91 (2011), 733–794.
85. Wright, E.M., Turk, E., The sodium/glucose cotransport family SLC5. Pflug. Arch. 447 (2004), 510–518.
86. Wu, P., He, P., Zhao, S., Huang, T., Lu, Y., Zhang, K., Effects of ursolic acid derivatives on Caco-2 cells and their alleviating role in streptozocin-induced Type 2 diabetic rats. Molecules 19 (2014), 12559–12576.
87. Xie, J., Gong, Q., Liu, X., Liu, Z., Tian, R., Cheng, Y., Su, G., Transcription factor SP1 mediates hyperglycemia-induced upregulation of roundabout4 in retinal microvascular endothelial cells. Gene 616 (2017), 31–40.
88. Xie, Y., Chen, S., Wu, Y., Murphy, T.H., Prolonged deficits in parvalbumin neuron stimulation-evoked network activity despite recovery of dendritic structure and excitability in the somatosensory cortex following global ischemia in mice. J. Neurosci. 34 (2014), 14890–14900.
89. Yamazaki, Y., Arita, K., Harada, S., Tokuyama, S., Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1. J. Pharmacol. Sci., 2018 in press.
90. Yamazaki, Y., Harada, S., Tokuyama, S., Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res. 1489 (2012), 113–120.
91. Yamazaki, Y., Harada, S., Tokuyama, S., Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia. Neurosci. Lett. 604 (2015), 134–139.
92. Yamazaki, Y., Harada, S., Wada, T., Hagiwara, T., Yoshida, S., Tokuyama, S., Sodium influx through cerebral sodium-glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage. Eur. J. Pharmacol. 799 (2017), 103–110.
93. Yamazaki, Y., Harada, S., Wada, T., Yoshida, S., Tokuyama, S., Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia. J. Pharm. Pharmacol. 68 (2016), 922–931.
94. Yamazaki, Y., Ogihara, S., Harada, S., Tokuyama, S., Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia. Neuroscience 310 (2015), 674–685.
95. Zehendner, C.M., Librizzi, L., Hedrich, J., Bauer, N.M., Angamo, E.A., de Curtis, M., Luhmann, H.J., Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption. PLoS One, 8, 2013, e82823.
96. Zhang, W., Zhang, L., Hou, W., Xu, Y., Xu, H., Lou, F., Zhang, Y., Wang, Q., Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin. Med. J. (Engl.). 122 (2009), 1996–2001.
97. Zhen, Y., Ding, C., Sun, J., Wang, Y., Li, S., Dong, L., Activation of the calcium-sensing receptor promotes apoptosis by modulating the JNK/p38 MAPK pathway in focal cerebral ischemia-reperfusion in mice. Am. J. Transl. Res. 8 (2016), 911–921.
98. Zheng, L.-S., Ishii, Y., Zhao, Q.-L., Kondo, T., Sasahara, M., PDGF suppresses oxidative stress induced Ca2+ overload and calpain activation in neurons. Oxid. Med. Cell. Longev., 2013, 2013, 367206.
99. Zhou, L., Cryan, E.V., D'Andrea, M.R., Belkowski, S., Conway, B.R., Demarest, K.T., Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1). J. Cell. Biochem. 90 (2003), 339–346.